BlackRock Institutional Trust’s Taro Pharmaceutical Industries Ltd. TARO Stock Holding History
Bought
Maintained
Sold
Other funds holding TARO
MICM
CG
BlackRock Institutional Trust's TARO Position: Q4 2016 in Review
BlackRock Institutional Trust reduced its Taro Pharmaceutical Industries Ltd. (TARO) stake by 0.21% in Q4 2016, selling an estimated $48K and leaving 221,071 shares worth $23.3M. The position accounts for ﹤0.01% of the portfolio, ranked #1859.
BlackRock Institutional Trust first reported a position in TARO in Q2 2013 and has held it in 15 quarters since. The position peaked at $30.9M in Q2 2016. 151 funds tracked by Wall St. Rank hold TARO as of Q4 2016.
- BlackRock Institutional Trust held 221,071 shares of Taro Pharmaceutical Industries Ltd. worth $23.3M as of Q4 2016.
- BlackRock Institutional Trust sold 458 Taro Pharmaceutical Industries Ltd. shares in Q4 2016, an estimated $48K.
- Taro Pharmaceutical Industries Ltd. made up ﹤0.01% of BlackRock Institutional Trust's portfolio in Q4 2016, its #1859 holding.
- BlackRock Institutional Trust first reported a position in Taro Pharmaceutical Industries Ltd. in Q2 2013 and has held it in 15 quarters since.
- BlackRock Institutional Trust's Taro Pharmaceutical Industries Ltd. position peaked at $30.9M in Q2 2016.
- 151 funds tracked by Wall St. Rank held Taro Pharmaceutical Industries Ltd. as of Q4 2016.
Based on BlackRock Institutional Trust's 13F filing for Q4 2016, filed 10 Feb 2017.